pharmaceuticals

Written approval required for bimekizumab, guselkumab

Eli Lilly pulls PBS application for eczema drug

Exciting updates in rosacea management

Upadacitinib shows promise for papulopustular rosacea in pilot study

‘Major step forward’: TGA approves first pharmacological therapy for OSA

New consensus for JAKi use in AD

Oral JAKi improves phototherapy-induced repigmentation in vitiligo

New authority requirement adding to the PBS ‘clickfest’
